October 20, 2020
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, October 2020

What are the elements of a productive meeting when we get together – and what might they look like in a virtual format?
October 19, 2020
Doctor on laptop

Virtual ECOG-ACRIN Fall 2020 Group Meeting: What to Expect

The Fall 2020 Group Meeting will look different this year – a fact that should not be too surprising, given that it will take place entirely online
October 19, 2020

Trial Results: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

The Journal of Clinical Oncology published new data from the NCI-MATCH precision medicine cancer trial that has broad relevance in medicine and provides a roadmap for future precision medicine trials
October 19, 2020
TMIST accrual bar graph

TMIST Breast Cancer Screening Trial Rebounds from COVID-19 Shutdown of Cancer Screenings

October accrual is on pace to be the highest month on record. Since July 1, TMIST has enrolled more patients than all other National Cancer Institute clinical trials combined. An unheard-of number (nearly 20%) are Black and African American women. Drs. Etta Pisano and Mitch Schnall provide the latest status of the trial and discuss its continuing relevance
October 19, 2020
Young Investigator headshots

Meet the 2020 Young Investigator Symposium Presenters

The purpose of the Symposium is to introduce young investigators to ECOG-ACRIN and provide them with a forum to present their research in a formal manner and obtain feedback
October 19, 2020
Blood pressure machine

Now Enrolling: EAQ191 / CARISMA for management of hypertension in patients with metastatic renal cell or thyroid cancer on anti-angiogenic tyrosine kinase inhibitors

This phase II study, led by Dr. Bonnie Ky, aims to generate the necessary data to inform a phase III randomized controlled trial with the potential to make a significant public health impact
October 19, 2020
News in Brief

News in Brief, October 2020

September 14, 2020
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, August/September 2020

Welcome to the News From ECOG-ACRIN blog; COVID-19 month six reflections; clinical trial enrollment continues to improve; EA Cancer Research Advocates Committee adds five new members
September 14, 2020
Lungs

Now Enrolling: EAQ172 for Treatment of Lung Inflammation in Patients with Any Type of Cancer

This phase II trial by EA's Cancer Control and Survivorship Committee is comparing two promising pneumonitis treatments for patients receiving PD-1/PD-L1 therapy
September 14, 2020
PrECOG logo

Trial Results: PALbociclib CoLlaborative Adjuvant Study (PALLAS)

A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence
September 14, 2020
Woman virtual presentation

2020 Young Investigator Symposium (A Virtual Event)

Up to eight young investigators will present their work at the annual Young Investigator Symposium, taking place during the Virtual Fall 2020 Group Meeting
September 14, 2020
Ingrid Mayer, MD

Trial Spotlight: Ingrid Mayer on Study EA1131 for Triple-Negative Breast Cancer, Including Men

This is the only study that is currently designed to test the ability to improve long-term outcomes by refining early-setting triple-negative breast cancer chemotherapy without exposing ALL patients to more toxicity preoperatively